GeNeuro SA
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical tr…
Biotechnology
CH, Plan-les-Ouates [HQ]
GNRO.PA/Leadership and Strategy
Risk Factors
By Management
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.